Perfinity Biosciences, Inc.

Bial-portela Ca & S.a.

Perfinity Bioscices, Inc.

Kevin Wayne Meyer

Nicholas Brian Herold

Derrick Nathaniel Poe

John Patrick O'Grady

David Alexander Learmonth

Fred E Regnier

Keith Lorimer

Tibor Eszenyi

Robert Harold Ellis

Bob Harold Ellis

Álmosné Kovách

Nicholas B Herold

Almosne Kovach

This disclosure provides a single reactor that accommodates an affinity selector to separate analytes of interest, and an enzyme reactor that digest the analyte to suitable peptides for mass spectrometry. The single reactor formats described herein accommodate workflows wherein separation precedes digestion as well as workflows wherein digestion precedes separation selection.

Single reactor for simplified sample preparation workflows

The disclosure provides an innovative immobilized enzyme reactor working system that includes improved reactor formats, heating element, optimum buffers, filtration apparatus and collection componentry for easy to use sample preparation. The system provides enhanced recovery, improved reproducibility and parallel processing capabilities capable of quantitatively processing hundreds of difficult to digest samples simultaneously in a shortened period of time.

Robust, easy to use immobilized enzyme reactors

This invention relates to novel polymorphs of (HO)NO(CH)&#x2014;(CNO)&#x2014;(CN)(CH)ClO, to processes for their preparation, and to pharmaceutical compositions containing said novel polymorphs as active pharmaceutical ingredient.

Crystal forms of 5-[3-(2,5-dichloro-4, 6-dimethyl-1-oxy-pyridine-3-yl)[1,2,4] oxadiazol-5-yl]-3-nitrobenzene-1,2-diol

A multi-dimensional method for simultaneously analyzing multiple analytes within a sample solution, comprising adding affinity selectors to a sample solution containing analytes to be measured, the affinity selectors having an affinity for one or more of the analytes within the sample solution; allowing immune complexes to form between the affinity selectors and the analytes; partially or totally resolving the formed immune complexes from non-analyte substances within the sample solution; dissociating the resolved immune complexes; separating the analytes and the affinity selectors of the dissociated immune complexes from one another by capturing the analytes through a surface adsorption process; transferring the captured analytes to a detection means; and resolving the analytes with the detection means in accordance with their mass-to-charge ratios.

Affinity selector based recognition and quantification system and method for multiple analytes in a single analysis

Growing community of inventors

West Lafayette, IN, United States of America

Kevin Wayne Meyer